… Irradiation-induced CXCL12 upregulation and consequent recruitment of bone marrow-derived
cells (BMDCs) enhanced tumor vasculogenesis in an orthotopic mouse model of …

… mouse has been used once as a preclinical model for prostate cancer but without orthotopic
… In the present study, the Nod Scid mouse has been used for subcutaneous and orthotopic …

… -derived Orthotopic Prostate Syngeneic (TOPS) mouse model was … tumor and metastatic
responses to novel treatments. … novel orthotopic prostate cancer xenograft mouse model named …

… The human prostate cancer models were established by orthotopic implantation of PC-3
and LNCaP cells in nude mice. I 131 -PSCA-mAb distribution and tumor cell apoptosis in the …

… mouse model were repeated in the RM-9 orthotopic prostate … of LNCaP cells in SCID mice
similar to our model, the soy … Our study in prostate cancer orthotopic models does not address …

… prostate cancer (PCa) experience bone metastasis, which negatively impacts overall survival
and patient quality of life. Various mouse models have … For instance, orthotopic models of …

… orthotopic model, desmopressin treatment was administered by two intravenous injections
covering a 24-h time period following chemotherapy treatment. … -resistant prostate cancer cells …

… to establish translatable mouse models of disseminated prostate cancer (… Orthotopic primary
tumors enable response assessments to different therapies. Systemic cancer mouse models…

… mouse models of cervical cancer [19] and prostate cancer [50]. In addition, both minodronate
and zoledronate affect VEGF interaction with VEGF receptors and signaling in endothelial …

… Using the RM-9 murine model for prostate we clearly demonstrated significant antitumor
and systemic antimetastatic activities of a single in situ injection of IL-12. It should be …